Intravenous infusion of curcumin and a calcium channel blocker
US8747890B2 · kind B2 · utility
14Cited by
6References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 19, 2010 |
| Grant date | Jun 10, 2014 |
| Priority date | — |
| Expiry date | Nov 1, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/127
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for treating systemic diseases by intravenous administration of formulations of synthesized curcumin (diferuloylmethane) and concomitantly a calcium channel blocker to human subjects with neoplastic and neurodegenerative diseases are disclosed herein. The diseases are treated by prolonged administration of sub-optimal doses of liposomal curcumin or polymeric nanocurcumin or the sustained release curcumin from PLGA nanocurcumin at dosages below systemic hemolytic thresholds concomitantly with or without calcium channel blockers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.